Your binder contains too many pages, the maximum is 40.
We are unable to add this page to your binder, please try again later.
This page has been added to your binder.
London WC2R 1BH
+44 20 7067 2000
Over 100 fee-earners combine their regulatory, corporate, and litigation strengths with deep industry knowledge, advising clients on cutting edge legal, technical, and compliance matters.
Our capabilities in London include regulatory law (across multiple industries), corporate and commercial transactions, anti-corruption and compliance, dispute resolution, international employment and mobility, insurance, trade controls, intellectual property, real estate and tax.
Our broad industry experience includes life sciences, technology, financial services, media and communications, energy, branded goods and sports industries.
September 28, 2016, Covington Alert
Provisions of a new French law, adopted on September 28, 2016, will loosen France’s rules around videogaming contests in France, and lay down new labor regulations for professional gamers. For now, clients ought to exercise significant caution before arranging French eSports contests or entering into contracts with professional gamers in France. Even after the ...
September 26, 2016
LONDON—Graham Vinter, General Counsel of BG Group plc from 2007 until 2015, has joined Covington’s London office. Mr. Vinter will chair the firm’s Project Finance practice and supervise an expansion of the firm’s capabilities in this area.
At BG Group, Mr. Vinter was a member of the Group Executive Committee and reported to the Chief Executive Officer. He was ...
September 26, 2016, Legal Week
Timothy Hester and Graham Vinter are quoted in a Legal Week article regarding Vinter’s recent arrival. According to Hester, "We see an opportunity at Covington to build a leading projects practice that also provides synergies with other parts of the firm - in particular, arbitration, government affairs, tax, corporate, IP, and energy regulation. As we move along ...
September 26, 2016, The Lawyer
Timothy Hester and Graham Vinter are quoted by The Lawyer in an article regarding Vinter’s arrival. According to Hester, Vinter’s hire was “an opportunity to build a leading projects practice that also provides synergies with other parts of the firm – in particular, arbitration, government affairs, tax corporate, IP and energy regulation.”
Vinter adds, ...
September 26, 2016, Legal Business
Timothy Hester and Graham Vinter are quoted in a Legal Business article regarding Vinter’s arrival as chair of Covington’s Project Finance practice. Hester describes Vinter as a “veteran of the project finance industry [who] is highly respected worldwide for his unparalleled knowledge of the sector.” He adds, “We see an opportunity at Covington to build a ...
September 21, 2016, Covington Alert
On September 21, 2016, the Court of Justice of the EU (CJEU) delivered its judgment in Case C-592/14 European Federation for Cosmetic Ingredients v UK Secretary of State for Business. The Court has ruled that animal tests performed outside the European Union (EU) to comply with non-EU rules should not be used for the product safety assessment to gain access to ...
September 20, 2016, Law360
September 19, 2016, Covington Alert
In 2015, the UK government introduced a requirement for certain companies to make annual statements on action taken to eradicate slavery and human trafficking from their businesses and suppliers. The publication deadlines for the first organisations caught by the rules expire in September and recent statements issued by businesses across a variety of sectors ...
September 19, 2016, Law360
Carlo Kostka is quoted in a Law360 article regarding the UK’s diminishing influence over EU banking regulation following the Brexit vote. According to Kostka, "There's a broad concern that the expertise of the UK has been very positive to the EU's financial rulemaking in general.” He continues, “So to the extent that that's taken away by definition because the ...
September 12, 2016, Global Arbitration Review
Greg Lascelles and Alex Leitch are quoted in a Global Arbitration Review article regarding Lascelles’ recent arrival to Covington. “I am very excited to join this growing team,” says Lascelles.
According to Leitch, the financial services sector attracts significant client demand and Lascelles’ arrival is a “welcome addition” to the practice.
September 5, 2016
LONDON—Greg Lascelles has joined Covington as a partner in the European Dispute Resolution practice resident in the firm’s London office.
Mr. Lascelles has a broad litigation and arbitration practice covering a variety of industry sectors, with a particular focus on financial services. He advises hedge funds, private equity houses, asset managers, investment ...
August 26, 2016, Nutritional Outlook
Brian Kelly is quoted in a Nutritional Outlook article regarding the ways Brexit could affect the supplement industry. According to Kelly, “If the UK went down a Norway or EEA model approach, it’s very unlikely that there’d be any material change to the legal position.” He continues, “The UK’s implementation of EU existing food law would remain valid and the UK ...
August 12, 2016, Covington Alert
The Insurance Act, which received Royal Assent and became law in the United Kingdom in February 2015, has now come into force: it applies to all insurance policies entered into on or after August 12, 2016, including renewals, and to all variations to existing policies made on or after that date.
As previously reported, the Act contains the most significant ...
August 5, 2016, FDA Week
Grant Castle is quoted in an FDA Week article regarding the likelihood that the UK will remain part of the Mutual Reliance Initiative between the U.S. and EU. "If the UK does Brexit, but executes the European Economic Area (EEA) Agreement, as Norway, Iceland and Liechtenstein have done, it would continue to implement all new EU pharmaceutical rules and ...
July 28, 2016, Covington Alert
The UK is currently the largest financial centre in the European Union (“EU”). A large number of global financial institutions have a presence in the UK, both in order to participate in the UK financial market and also as a hub to access clients and markets across the EU. Whatever form Brexit takes, it will have an enormous impact on the financial services ...
July 21, 2016, Covington Alert
While the UK’s decision to leave the EU could bring about significant changes to the UK’s legal and economic landscape, we cannot yet know how wide-ranging these changes will be. It is generally agreed that the changes will be fairly dramatic if the UK is unable to negotiate a deal that will maintain its access to the single market, or if the eventual deal ...
July 19, 2016, Global Competition Review
Alex Leitch and Jeremy Wilson are quoted in a GCR article regarding the arrival of Elaine Whiteford to Covington’s European dispute resolution practice. “We are thrilled with Elaine’s decision to join the firm. She brings a wealth of EU litigation experience, which we see as a real asset in the current market.”
July 18, 2016, Legal Business
Alex Leitch is quoted in a Legal Business article regarding the arrival of Elaine Whiteford to the firm’s European competition practice. According to Leitch “She brings a wealth of EU litigation experience, which we see as a real asset in the current market, impacted by many developments around Europe, including Brexit related disputes, and the new class action ...
July 18, 2016, Legal Week
Alex Leitch is quoted in a Legal Week article regarding the arrival of Elaine Whiteford to the firm’s European competition practice. According to Leitch, “[Whiteford] brings a wealth of EU litigation experience, which we see as a real asset in the current market, impacted by many developments around Europe, including Brexit related disputes, and the new class ...
July 15, 2016
NEW YORK—Covington advised Medical Research Council Technology, a UK-based independent life science medical research charity, in its sale of a portion of the royalty stream associated with its cancer drug Keytruda® for $150 million (£115.6 million).
Keytruda® (pembrolizumab), is a new generation treatment which stimulates the body’s immune system to fight ...
July 14, 2016, Covington Alert
At a joint press conference on July 12, 2016 in Brussels, EU Commissioner for Justice, Consumers and Gender Equality, Věra Jourová and the U.S. Secretary of Commerce, Penny Pritzker, presented the Privacy Shield (see Press Release here, Adequacy Decision text here, Annexes here, Communication here, and Q&A factsheet here). The press conference followed the ...
July 13, 2016, Legal Business
Alex Leitch is quoted in a Legal Business article regarding Greg Lascelles’ upcoming arrival to Covington as a partner in the firm’s European Dispute Resolution practice. According to Leitch, “Financial services remains an active sector that attracts a lot of demand from our clients across a variety of disciplines, including antitrust litigation, commercial ...
July 13, 2016, Legal Week
Alex Leitch is quoted in a Legal Week article regarding the upcoming arrival of Greg Lascelles as a partner in the firm’s European Dispute Resolution practice. “Greg’s arrival will be another welcome addition to an already vibrant practice,” Leitch says. According to Leitch, “Financial services remains an active sector that attracts a lot of demand from our ...
July 11, 2016, Covington Alert
The UK recently voted to leave the European Union in an advisory referendum. The impact of Brexit on medical devices regulation in the medium-to-long term will very much depend on the form a post-Brexit UK will take, the relationship that the UK chooses to have with the EU, and indeed the relationship that the EU is willing to accept. That will not become clear ...
July 5, 2016, CDR News
Peter Camesasca and Alex Leitch are quoted in a CDR article regarding the long-term effects of Brexit on the courts, including uncertainties over enforcement. According to Camesasca, “This will not be immediate. Companies are not making any immediate decisions about litigation in the wake of the Brexit vote. Most are in ‘wait and see’ mode.” He continues, “But ...
On June 23, 2016, the UK voted in an advisory referendum to leave the European Union. The impact of Brexit in the medium-to-long term will very much depend on the form a post-Brexit UK will take, the relationship that the UK chooses to have with the EU, and the relationship that the EU is willing to accept. That will not become clear for some time as it will ...
July 2016, eHealth Law & Policy
June 30, 2016, Covington Alert
Last week, the UK voted to leave the European Union in an advisory referendum. The impact of Brexit on food and drink regulation in the medium-to-long term will very much depend on the form a post-Brexit UK will take, the relationship that the UK chooses to have with the EU, and indeed the relationship that the EU is willing to accept. That will not become clear ...
June 30, 2016, Politico
Grant Castle is quoted in a Politico article regarding Britain’s desire to continue its dominance in health research. Commenting on the possibility of having Britain stay in the single market, Castle says, “I don’t think that’s a practicality now.” He continues, “I would think that access to the country would be tightened…given the strength of feeling on ...
June 29, 2016, Covington Alert
Following the vote by the United Kingdom in an advisory referendum to leave the European Union (“EU”), there is no immediate change to employment law in the UK.
Assuming that the referendum decision is put into effect (which still appears to be subject to significant political, legal and practical obstacles), the extent of any future changes will of course ...
June 28, 2016, Bloomberg
Grant Castle is quoted in a Bloomberg article regarding the implications of Brexit on the future of the pharmaceutical industry and the drug approval process. According to Castle, the best that the UK regulator could hope for would be an observer status on European Medicines Agency committees. That loss of influence could make the UK less appealing, because it ...
June 28, 2016, Covington Alert
The SEC’s Division of Corporation Finance (the “Division”) recently issued updated interpretive guidance on the use of non-GAAP financial measures. This guidance reflects an increasingly assertive position taken by the SEC in recent months regarding public companies’ use of numerical measures of performance, financial position or cash flows that are not ...
June 27, 2016, Covington Alert
Last week, the UK voted in an advisory referendum to leave the European Union. The next steps are not yet clear, but the referendum may have significant implications for the pharmaceutical industry in the UK and for international companies operating in the UK. Its impact will very much depend on the form a post-Brexit UK will take, the relationship that the UK ...
June 27, 2016, The Legal Intelligencer
Grant Castle is quoted in a Legal Intelligencer article regarding the regulatory impact of Brexit. Commenting on the Food and Drug sector, Castle says, “The UK will inevitably diminish in significance when it comes to the regulation of pharmaceuticals and a venue where drug companies are going to want to be based. Historically, U.S. companies wanted to operate ...
June 24, 2016, Covington Alert
The UK has voted to leave the European Union in an advisory referendum. 52% leave - 48% remain.
Were the UK to leave the EU, this would have significant implications for the UK and for international businesses operating in the UK. The longer term impact of the decision on the regulatory framework for the UK will depend, in part, on the relationship that the UK ...
June 24, 2016, The Wall Street Journal
Louise Nash is quoted in a Wall Street Journal article regarding concerns raised following the Brexit vote. “The message we’re sending to our clients is that this is a hugely significant decision and will have great implications for the UK and for businesses that operate in the UK but…until the UK negotiates terms [to exit the EU], it is business as usual, our ...
June 24, 2016, Politico
Grant Castle is quoted in a Politico article regarding the effect of Brexit on the future location of the European Medicines Agency. Castle predicts that the EMA is inevitably going to leave the UK. “Given the strength of feeling on immigration,” it looked unlikely the country would opt for a European Economic Area relationship, since that would mean continuing ...
June 22, 2016, The Wall Street Journal
David Lorello is quoted in a Wall Street Journal article regarding the possible regulatory changes that may come as a result of Brexit. According to Lorello, commenting on potential changes to the sanctions regime, “If the UK leaves the EU, it may no longer be required to implement those sanctions, but it all depends on how Brexit would be negotiated.”
June 21, 2016, Webinar
June 21, 2016
SILICON VALLEY—Covington advised Tencent Holdings Limited, a leading provider of internet service in China, in connection with its acquisition of a majority stake in Supercell from SoftBank. A consortium established by Tencent will acquire up to 84% of Supercell for $8.6 billion in a transaction valuing Supercell at approximately $10.2 billion.
Supercell is a ...
June 17, 2016
LONDON—Euromoney Legal Media Group has selected four Covington lawyers for its annual “Europe Women in Business Law Awards.” The awards honor women in the legal sector across Europe.
The Covington lawyers recognized are:
Louise Nash, Best in Mergers & Acquisitions. Ms. Nash focuses on M&A and other transactional matters for clients in the consumer brands, ...
June 7, 2016, Commercial Dispute Resolution
Kenny Henderson participated in CDR’s Spring Competition Litigation Symposium and is quoted in this article regarding the barriers which are hampering the progress of the new UK collective actions regime. According to Henderson, “It is fairly clear, in my view, that the CAT guidance suggests it is looking for a very business-like, rapid approach to the question ...
June 3, 2016
NEW YORK—Covington advised the underwriters in connection with Repligen’s $115 million debt offering. The senior convertible notes due in 2021 were placed at 2.125 percent.
Repligen is a bioprocessing company focused on the manufacture of Protein A ligands used by life science companies to purify biologic drugs such as monoclonal antibodies, recombinant ...
June 2016, eHealth Law & Policy
May 26, 2016
NEW YORK—Corporate Board Member magazine has once again named Covington to its list of the top 25 corporate law firms. The “America’s Best Corporate Law Firms” survey asks directors and general counsels at publicly traded companies to identify the firms they would most likely retain for a variety of legal matters.
“Covington is proud that we are regarded by our ...
May 26, 2016, The Wall Street Journal
David Lorello is quoted in a Wall Street Journal article regarding a recent call to review the UK Serious Fraud Office’s (SFO) funding model after increased scrutiny of the SFO’s governance structure. According to Lorello, “The blockbuster funding has been a matter of significant public attention for some years now." He continues, “As with many government ...
May 23, 2016, The Law Society Gazette
Alex Leitch, Carlo Kostka, and Richard Mattick participated in a roundtable with The Law Society Gazette regarding the UK Insurance Act 2015. Leitch, pointing at “fair presentation,” a grey area in the new legislation, said a policyholder will want to make sure that they have “discharged the duty of giving a fair presentation of the risk which is going to be ...
May 22, 2016, Business Insurance
Richard Mattick is quoted in a Business Insurance article regarding the UK Enterprise Act. According to Mattick, the new Act, which updates one element of the Insurance Act 1886 that was left out of the Insurance Act 2015, “remedies a long-standing injustice for insurance policyholders.” It marks the first time that policyholders can seek damages for late ...
May 12, 2016, Webinar
May 11, 2016, This article was published in Scrip Regulatory Affairs
May 9, 2016, Covington Alert
On May 4, 2016 the Enterprise Act received the Royal Assent and became law in the UK. Once its relevant provisions come into force on May 4, 2017, it will introduce for the first time into English law a right for policyholders to recover damages for late payment of insurance claims from insurers (Scottish law already recognizes an implied obligation for an ...
May 8, 2016, Financial Times
Peter Bogaert and Grant Castle are quoted in a Financial Times article regarding the effect Brexit would have on the UK pharma industry. According to Bogaert, commenting on the important relationship between the European Medicines Agency and the UK’s Medicines and Healthcare Products Regulatory Agency, “Brexit would be a loss for both sides.”
Castle adds that ...
May 2016, eHealth Law & Policy
April 29, 2016, The Wall Street Journal
Charlotte Hill is quoted in this Wall Street Journal article discussing the new UK market abuse rules. According to Hill, “The scope of the new market abuse regime is much wider than the previous regime.”
April 21, 2016
NEW YORK — Covington has partnered with Columbia Law School and its Center for International Commercial and Investment Arbitration to launch the Covington Academy on International Arbitration (CAIA). The program is open to Columbia’s J.D., LL.M, and S.J.D. students.
The three-day program will consist of training followed by practical exercises and live feedback ...
April 21, 2016, Covington Alert
On April 5, 2016, the United States Department of Justice (“DOJ”), through the Criminal Division’s Fraud Section, announced a one-year Foreign Corrupt Practices Act (“FCPA”) enforcement pilot program (the “Pilot Program”) intended to motivate companies to voluntarily disclose FCPA-related misconduct and increase transparency around the Fraud Section’s approach ...
April 20, 2016
BRUSSELS — Sophie Bertin, a former senior official who served as Head of Unit in the “Financial Crisis” Task Force within the Directorate-General for Competition at the European Commission, has joined forces with Covington’s global antitrust and competition practice. Ms. Bertin will be working with the firm’s Brussels and London offices.
At DG COMP, Ms. Bertin ...
April 15, 2016, The Wall Street Journal
Charlotte Hill is quoted in The Wall Street Journal’s “Morning Risk Report” discussing the Financial Conduct Authority’s consultation paper. According to Hill, improving transparency and efficiency is part of the reform that is making the FCA a “very much tougher” regulator.
April 14, 2016, Covington Alert
Latest figures suggest that women in the UK still earn on average 20 percent less than men. Companies that fail to address gender pay differences will be highlighted in league tables under the new Gender Pay Gap Regulations. The draft regulations require private employers in the UK to collect and publish information showing differences in pay between male and ...
April 12, 2016, Law360
April 2016, Covington Alert
Right to Private Life v. Right to Monitor
On January 12, 2016, the European Court of Human Rights published its judgment in another case concerning an employee’s use of company information systems, once again highlighting the challenge of balancing an employee’s right to a private life against the right of an employer to monitor employees at work.
April 4, 2016
BRUSSELS — Kevin Coates, a former senior official who served as Head of one of the Cartels Units at the Directorate-General for Competition at the European Commission between 2012 and 2016, has joined Covington’s antitrust and competition practice.
Over the last 16 years, Mr. Coates has held several senior positions within DG COMP and before that served as ...
April 1, 2016
WASHINGTON, DC — Covington has promoted eight lawyers to of counsel and eight to special counsel, effective April 1, 2015.
The new of counsel are as follows:
Stefanie Doebler (Washington) focuses her practice on health care compliance matters for pharmaceutical and medical device clients. She provides advice related to advertising and promotion, fraud and abuse, ...
April 2016, eHealth Law & Policy
Philippe Bradley-Schmieg is quoted in this eHealth & Policy Law article regarding WHO’s report on key eHealth trends and progress across Europe. According to Bradley-Schmieg, “The call for ‘detailed’ EHR [electronic health record] laws is questionable. German and French EHR laws have simply added to already tough and complicated legal environments, with ...
March 31, 2016, Global Competition Review
Peter Camesasca discusses private cartel actions in the European Union in this interview with GCR.
March 24, 2016
NEW YORK - Covington advised the underwriters in the $45 million initial public offering of common stock of Senseonics Holdings, Inc. The offering closed on March 23, 2016. Shares of Senseonics trade on the NYSE MKT under the ticker “SENS.”
Senseonics develops continuous glucose monitoring systems for patients with diabetes. Its Eversense product consists of ...
March 24, 2016, The Wall Street Journal
Daniel Cooper is quoted in The Wall Street Journal’s “Morning Risk Report” discussing how companies should best comply with global data protection regulations. Commenting on the binding corporate rule process, Cooper said,“The one thing we know about binding corporate rules is [they tend] to have more appeal to European regulators.” He continues, “For a lot of ...
March 22, 2016, The Wall Street Journal
Charlotte Hill is quoted in The Wall Street Journal’s “Morning Risk Report” discussing the shake-up of the U.K. Stewardship Code. According to Hill, "Not only will fund managers have an increased burden in relation to their clients, but they will also have a significantly increased responsibility to the FRC.”
March 17, 2016, Covington Alert
March 17, 2016, Law360
March 16, 2016, Covington Alert
March 11, 2016, Global Competition Review
Johan Ysewyn is quoted in this GCR article covering Société Générale’s decision to drop its appeal after the European Commission agreed to reduce the penalty. According to Ysewyn, “If the reduction is substantial, the danger is that, in the future, this would be read as a precedent by other companies who settle and would try their luck in court.”
March 9, 2016, Covington Alert
March 8, 2016, Global Competition Review
Alex Leitch and Kenny Henderson are quoted in this GCR article discussing the launch of the first opt-out class action in the UK.
According to Leitch, “If the case is not settled and the class is granted a collective proceedings order, this will be the trickle that may form into a steady flowing stream.” He continues by stating that the class seems to be ...
March 8, 2016, Covington Alert
March 7, 2016, Covington Alert
March 7, 2016
LONDON — Carlo Kostka has joined Covington’s global financial institutions practice resident in the firm’s London office.
Most recently Mr. Kostka served as co-head of UniCredit's legal department, where he was responsible for international legal operations, including all legal matters related to the corporate and investment banking division, significant ...
March 2, 2016, Covington Alert
March 1, 2016
LONDON — Covington advised AstraZeneca on an agreement with ProStrakan Group, a subsidiary of Kyowa Hakko Kirin Co. Ltd., for the rights to Moventig (naloxegol) in the European Union (EU), Iceland, Norway, Switzerland and Liechtenstein.
Moventig is the first once-daily, oral peripherally-acting mu-opioid receptor antagonist (PAMORA) approved in Europe for the ...
Spring 2016, GC Magazine
Lisa Peets spoke with GC Magazine regarding Covington’s approach to diversity. Peets says, “We approach diversity from two perspectives. First, how do we build the pipeline, and second, how do we recruit and retain internally?”
March 2016, eHealth Law & Policy
February 26, 2016, Nutra Ingredients
Brian Kelly is quoted extensively in this Nutra Ingredients article discussing the UK Psychoactive Substances Act and its possible effect on the food supplements industry. According to Kelly, “Despite criticism and proposed amendments about unintended targets the law has been pushed through. It’s a poorly drafted law when it comes to food.” He continues, “You ...
February 22, 2016, The Law Society Gazette
Johan Ysewyn is quoted by The Law Society Gazette in an article discussing changes in competition policy and enforcement, and what these changes mean for lawyers. “The commission likes its fines, but I think it takes a balanced view that it also likes companies changing their trading behaviour,” says Ysewyn. Ysewyn continues by commenting on the changing nature ...
February 19, 2016, Law360
Mark Young and Libbie Canter are quoted in this Law360 article offering tips on how deal makers can mitigate cybersecurity risks.
According to Young, any discovered incidents can give buyers pause on how — and if — they want to move forward. “We’ve dealt with at least a couple examples where deals were at least delayed if not reconsidered because of ...
February 18, 2016, Covington Alert
February 17, 2016, Covington Alert
February 17, 2016, Politico
Grant Castle and Robin Blaney are quoted in this Politico article discussing the potential impact of “Brexit” on the pharmaceutical sector in the UK and Europe. According to Castle, the “only rational alternative” to EU membership is for the U.K. to become a member of the European Economic Area, as this arrangement would make it so the practical and operational ...
February 12, 2016, Covington Alert
February 5, 2016, LexisNexis
February 2, 2016, Covington Alert
February 2016, European Journal on Risk Regulation
January 29, 2016, Covington Alert
January 28, 2016
WASHINGTON, DC - Law360 has named six Covington practice groups among its “Practice Groups of the Year.”
The practice groups recognized by Law360 are as follows:
January 27, 2016, Covington Alert
January 13, 2016
LONDON — Covington advised AstraZeneca, along with its global biologics research and development arm, MedImmune, on a new collaboration with Moderna Therapeutics to discover, co-develop and co-commercialize messenger RNA (mRNA) therapeutic candidates for the treatment of a range of cancers. The collaboration is in addition to the agreement announced by the ...
January 8, 2016, Covington Alert
December 28, 2015, Covington Alert
December 23, 2015, Bloomberg Business
Louise Nash was interviewed by Bloomberg Business television for a live segment featured on “Countdown,” discussing the 2015 M&A market and its high volume of transactions.
December 21, 2015, Law360
Kenny Henderson is quoted in a Law360 article discussing the significant risk for companies bringing follow-on lawsuits based on enforcement decisions in light of the European Commission’s decision to overturn €790 million ($865 million) worth of price-fixing fines against some of the world's biggest airlines. According to Henderson, "Every twist and turn in ...
December 21, 2015, Covington Alert
December 18, 2015, Covington Alert
December 17, 2015
LONDON, 17 December, 2015 — Covington advised AstraZeneca on its acquisition of Takeda’s respiratory business. Under the terms of the agreement, AstraZeneca will make a payment of $575 million, and approximately 200 staff will transfer to AstraZeneca upon completion.
The deal will include the expansion of rights to roflumilast (marketed as Daliresp in the ...
December 16, 2015, Covington Alert
December 11, 2015, Covington Alert
December 8, 2015, Law360
Mark Young is quoted in a Law360 article discussing the EU Network and Information Security Directive, which sets a cybersecurity and breach reporting baseline for both critical infrastructure operators, as well as digital service providers. This directive, which is the first of its kind, comes after two years of negotiations. According to Young, “There’s going ...
December 8, 2015
NEW YORK, December 8, 2015 - Covington represented Ascension, the nation’s leading Catholic and non-profit health system, in a $200 million investment transaction with TowerBrook Capital Partners in Accretive Health, a leading provider of revenue cycle management services to healthcare providers. The transaction is expected to close in the first quarter of ...
December 4, 2015, Policy and Regulatory Report
Kenny Henderson is quoted extensively in a PaRR article discussing the delay in opt-out class actions under the UK Competition Appeal Tribunal’s (CAT) new collective damages regime. Henderson argues that the claims have not materialised "because of uncertainty created by the transitional limitation regime."
December 2, 2015, Covington Alert
December 2015, E-Commerce Law and Policy
November 24, 2015, The Register
Dan Cooper is quoted by The Register in an article discussing the uncertainty and complications continuing to surround the Schrems decision that derailed Safe Harbour. Cooper stated that his business clients were both “surprise[d] and shock[ed]” by the European Court’s decision. “Businesses felt like the rug had been pulled out from under them,” said Cooper. ...
November 23, 2015
LONDON, November 23, 2015 — Covington represented Allergy Therapeutics, the AIM-listed specialty pharmaceutical company specializing in allergy vaccines, in the placement of ordinary shares raising approximately £11.5 million. The placement was conducted through an accelerated bookbuilding process with Panmure Gordon & Co acting as financial adviser, nominated ...
November 18, 2015
WASHINGTON, DC, November 18, 2015 - The Human Rights Campaign Foundation (HRC) has awarded Covington a perfect score of 100 percent for the eighth consecutive year on its Corporate Equality Index, a national benchmarking survey and report on corporate policies and practices related to LGBT workplace equality. Covington is among 400 major US businesses that ...
November 16, 2015
Covington hosted a media roundtable with Brick Court Chambers to discuss the UK class action regime, and the effect of rule 119 of the Competition Appeal Tribunal’s provision. The Times of London and Global Competition Review covered the discussion.
Kenny Henderson said the new rule doesn’t “fit the new environment” otherwise created by the Consumer Rights Act ...
November 12, 2015, Covington Alert
November 11, 2015, Global Competition Review
Johan Ysewyn is quoted in a Global Competition Review article discussing Belgium’s Competition Authority’s draft leniency guidelines that have been launched for public consultation. Ysewyn, who welcomed the guidelines, said the new draft policy is “definitely workable.” “Awarding natural persons being granted immunity regardless of the position in which they ...
November 11, 2015, Covington Alert
November 9, 2015, The Lawyer
London’s managing partner Christopher Walter discusses the allure of the London legal market to international law firms and how firms in London collaborate with other law firms on the continent in The Lawyer. Walter, who argues in favour of collaboration opportunities with key firms, states that “working with local firms gives us the resources and flexibility ...
November 5, 2015, Global Competition Review
Johan Ysewyn is quoted in a Global Competition Review article assessing Margrethe Vestager’s first year as European commissioner for competition. According to Ysewyn, “For the first time in quite a long while, [Europe has had] a combination of a commissioner who, I believe, understands the political nuances of competition law, and a director general who actually ...
October 29, 2015, Law360
Kenny Henderson is quoted by Law360 in this article about the London High Court’s dismissal of antitrust allegations Hausfeld LLP brought on behalf of members of a Chinese chamber of commerce. Henderson calls it a “cautionary tale” and “something firms are going to have to grapple with going forward because opt-out [class actions] are only possible for U.K. ...
October 15, 2015, Law360
Special counsel Kenny Henderson is quoted in this Law360 article that discusses the new UK antitrust class action system. "The U.K. is really trailblazing here," said Henderson. "On a U.K. level, if the world from the U.K.'s perspective doesn't stop turning ... maybe there will be a push toward broadening the U.K. mechanism beyond antitrust litigation to ...
October 12, 2015, Covington Alert
October 6, 2015, Al Jazeera
Dan Cooper appeared on the show to discuss the implications of the ECJ Schrems judgment.
October 6, 2015, Covington Alert
October 5, 2015
LONDON, October 5, 2015 — Covington is pleased to announce its support for the internationally acclaimed MA Fashion course at Central Saint Martins in London. As part of the relationship, Covington will offer several workshops over the duration of the course with the aim of helping students with some of the most pressing legal and business concerns they will ...
October 1, 2015, Covington Alert
September 30, 2015, Covington Alert
September 29, 2015, Law360
September 28, 2015, Financial Times
London partner Alex Leitch comments in a Financial Times article on the new UK legislation that will allow US-style class action lawsuits when there are breaches of competition law. If the rules are successful, lawyers predict class actions could be applied to other areas, said Mr. Leitch.
September 24, 2015, Covington Alert
September 23, 2015, InsidePrivacy Blog
September 14, 2015, Law360
September 14, 2015, Journal of European Competition Law & Practice
September 14, 2015, The Law Society Gazette
September 10, 2015, Covington Alert
September 4, 2015, Covington Alert
Autumn 2015, RM Professional
September 2015, Arbitration World, Co-author
August 17, 2015, Lawyer2B
August 2015, Data Protection Law & Policy
August 2015, Privacy Laws & Business International Report
August 2015, Privacy Laws & Business
Article written by Covington's Lisa Peets and Ezra Steinhardt.
July 27, 2015, Bloomberg
Quoting Covington's Louise Nash.
July 27, 2015, Global Arbitration Review
July 23, 2015, Global Arbitration Review
A piece on our new arbitration app quoting Marney Cheek, Jeremy Wilson and Steve Bond and mentioning William Lowery’s and Catherine Karia’s roles in developing the app.
July 23, 2015
LONDON, July 23, 2015 — Covington has launched a new app designed specifically for smart phones and tablets called ‘The Arbitration Handbook’.
The app compiles over 90 resources (arbitral rules, treaties, national laws and guidelines) commonly used in international arbitration into one convenient electronic resource, while enabling users to bookmark and ...
July 17, 2015, Webinar
July 15, 2015, Covington Alert
July 13, 2015, Covington Alert
July 13, 2015
LONDON, 13 July, 2015 — Covington is advising AIM-listed ReNeuron Group plc, a leading clinical stage stem cell therapy company, on its latest follow-on financing announced on 10 July. ReNeuron is raising £68.4 million by way of an institutional placing of new shares arranged by Cenkos Securities plc. The placing is conditional on the receipt of certain ...
7/10/2015, Covington Alert
July 7, 2015, Competition Law Insight
July 6, 2015
LONDON, July 6, 2015 — Euromoney Legal Media Group selected four Covington partners Louise Nash, Lucinda Osborne, Lisa Peets and Hilary Prescott for its annual European Women in Business Law Awards. The awards honor women who are leading the field in the legal sector across Europe.
Louise Nash won the award for Mergers & Acquisitions. Ms. Nash is a member of ...
July 2015, Tijdschrift voor Belgische Mededinging/Revue de la Concurrence Belge
July 2015, E-Commerce Law and Policy
July/August 2015, Legal Business
6/25/2015, Covington Alert
June 2015, Intellectual Property & Technology Journal
June 24, 2015
LONDON, June 24, 2015 — Covington advised Allergy Therapeutics plc, the AIM-listed specialty pharmaceutical company, on its recently announced acquisition of Alerpharma, S.A. a Spanish-based allergy immunotherapy company which previously spun out from Spanish biopharmaceutical company, Zeltia S.A.
Alerpharma’s principal operating subsidiary, Inmunal, markets ...
June 23, 2015, Covington Alert
June 23, 2015, African Law & Business
June 22, 2015, InsideEnergy&Environment Blog
June 18, 2015
LONDON, June 18, 2015 — Covington is pleased to announce that Stephanie Sarzana has joined the firm as special counsel, resident in the London office.
Ms. Sarzana’s practice focuses on international commercial arbitration and on complex commercial litigation. She has represented companies before a variety of international arbitration tribunals, under numerous ...
June 16, 2015, InsideEnergy&Environment Blog
June 12, 2015, InsidePrivacyBlog
June 8, 2015, Financial Times
Covington's Daniel Cooper is quoted regarding the legal implications of wearables in the workplace:
“Historically European regulators in the data protection area have been very sceptical you can ever get a valid employee consent — they feel that for existing employees, [the relationship] is almost inherently coercive.”
June 1, 2015, Law360
May 14, 2015, Covington E-Alert
May 13, 2015
LONDON, May 13, 2015 — Covington has advised AIM-listed Horizon Discovery Group plc on a £40.1 million accelerated bookbuild placing announced on May 1, 2015. The financing is being undertaken to raise £25 million in new money for the company through a primary offering and £15.1 million for certain shareholders through a sale of their existing shares. The ...
May 12, 2015, Covington E-Alert
May 12, 2015, Covington Alert
May 11, 2015, Covington E-Alert
May 6, 2015, Covington E-Alert
May 2015, Privacy Laws & Business UK Report
April 28, 2015, Money Laundering Bulletin
April 17, 2015, InsideEnergy&Environment Blog
April 1, 2015, Covington E-Alert
March 30, 2015, InsidePrivacy Blog
March 27, 2015
LONDON, 27 March, 2015 — Covington received 56 individual mentions and 29 practice mentions in the 2015 edition of Chambers Global. The guidebook, which ranks lawyers globally by pan-regional and country practice area, is designed to identify the most skilled legal practitioners based on the qualities most valued by clients.
The Covington lawyers selected as ...
March 26, 2015
BEIJING, March 26, 2015 -- Covington announced today that Grace Chen has joined the firm’s international employment practice in its Beijing office.
Ms. Chen has more than 15 years of experience working at international law firms in China, advising multinational companies on a range of projects including matters relating to employment law and employee benefits. ...
March 24, 2015, Covington E-Alert
March 18, 2015, Covington E-Alert
March 13, 2015, CDR News
March 12, 2015
LONDON, March 12, 2015 — Covington & Burling is pleased to announce that Alex Leitch is joining the firm’s London office as a partner.
Mr. Leitch is a solicitor advocate and advises and represents parties in complex, high value and high profile international disputes. His focus includes disputes arising out of financial markets, with an emphasis on regulatory ...
March 9, 2015, Covington E-Alert
March 6, 2015
LOS ANGELES, March 6, 2015 — Covington will open a new office in Los Angeles on March 9. The office will be staffed by current firm lawyers and three new senior lawyers and will focus initially on insurance coverage, media and content distribution, patent litigation, public policy/government affairs and white collar defense.
"We believe there is a strong base ...
March 2, 2015, Law360
March 2015, Life Sciences Law Review
February 27, 2015
LONDON, February 27, 2015 — Covington advised Heptares Therapeutics Limited on its announced sale to Sosei Group, a Tokyo-listed Japanese biopharmaceutical company with operations in Japan and the UK. Consideration consisted of $180 million cash at closing and up to an additional $220 million contingent upon the successful progression of Heptares’ pipeline and ...
February 25, 2015, Covington’s Life Sciences Essentials Webinar Series
February 20, 2015, InsideEnergy&Environment Blog
February 18, 2015, InsideEnergy&Environment Blog
February 10, 2015, Covington E-Alert
February 5, 2015
LONDON, 5 February, 2014 — Covington advised AstraZeneca on its acquisition of the rights to Actavis' branded respiratory business in the US and Canada for an initial consideration of $600 million on completion and low single-digit royalties above a certain revenue threshold. Upon completion of the transaction, AstraZeneca will own the development and commercial ...
January 27, 2015, Scrip Regulatory Affairs
January 27, 2015
WASHINGTON, DC, January 27, 2015 — Covington was named one of the top 2014 “Media and Entertainment Practice Groups of the Year” by Law360.Law360 highlighted the practice for its involvement in “the most-talked-about sports media rights deals last year,” including the NFL's Sunday Ticket agreement with DirecTV, Steve Ballmer’s bid for the Los Angeles Clippers, ...
January 26, 2015
LONDON, January 26, 2015 — Covington has advised Horizon Discovery Group plc on the acquisition of Haplogen Genomics GmbH for an initial consideration of £6 million in cash and the issue of new ordinary shares, with potential earn-out payments based on future performance to be satisfied by the issue of further new ordinary shares having an aggregate value of up ...
January 20, 2015, Covington E-Alert
January 16, 2015
WASHINGTON, DC, January 16, 2015 — For the second consecutive year, Law360 named Covington’s antitrust and competition practice one of the top “Competition Practice Groups of the Year.”Law360 recognized Covington for securing the dismissal of separate antitrust suits against clients Samsung Electronics Co. Ltd., JP Morgan Chase & Co., and Expedia, Inc. The ...
January 15, 2015
LONDON, January 15, 2015 — Covington & Burling advised Laboratorios Esteve, S.A. (Esteve) in a global multi-programme discovery and development collaboration with Mundipharma Laboratories GmbH and its independent associated company, Purdue Pharmaceuticals LP, to bring to market important next generation products for the management of pain. Under the agreements, ...
LONDON, January 15, 2015 — Covington & Burling advised OCP S.A. on the acquisition of approximately 10% of the share capital of Brazilian listed fertilizer company, Fertilizantes Heringer S.A., for R$145.415.034,00 (approximately US$55 million) and on a long-term supply agreement for phosphatebased products. OCP Group is the largest global producer of phosphate ...
January 13, 2015, Covington E-Alert
January 12, 2015, Covington E-Alert
January 2015, Regulatory Rapporteur
2015, Webinar, 24th Annual EU Pharmaceutical Forum
December 30, 2014, InsideEnergy&Environment Blog
December 22, 2014, Luxury Legal Post
December 16, 2014, Covington E-Alert
December 15, 2014, CDR News
Covington partner Jeremy Wilson is quoted regarding the liberalization of Korea’s legal market:
"Marking the start of a five-year liberalisation process of its legal services sector, the move has spawned an influx of over 20 international firms opening offices in Seoul. With restrictions lifted on firms providing dual advice with domestic practices in 2013, the ...
December 11, 2014, Covington E-Alert
December 10, 2014, Covington E-Alert
December 8, 2014, Covington E-Alert
December 2014, eHealth Law & Policy
December 2014, World Securities Law Report
November 25, 2014, Covington E-Alert
November 19, 2014
WASHINGTON, DC, November 19, 2014 — For the seventh consecutive year, the Human Rights Campaign Foundation has awarded Covington & Burling the top rating of 100 percent in the 2015 Corporate Equality Index. Covington’s rating reflects its support for same-sex partners of employees through health insurance, bereavement and family leave policies, as well as its ...
November 17, 2014
LONDON, 17 November, 2014 — Covington is advising Indivior, formerly RB Pharmaceuticals, in the demerger transaction announced today from Reckitt Benckiser, a global consumer products company. The demerger is subject to the approval of RB shareholders. Indivior PLC will be a specialty pharmaceutical company focused on the treatment of addiction and closely ...
November 6, 2014, InsideEnergy&Environment Blog
November 2014, Operational Risk & Regulation
October 28, 2014, Law360
Andrea Zulli is featured in this article regarding his move to Covington:
"Andrea Zulli, who will join Covington's EU competition group as of counsel, advises clients in all aspects of EU, international and Italian competition law, including merger control, cartels and other restrictive practices, antitrust compliance and abuses of a dominant position."
October 27, 2014, GCR
This article features Andrea Zulli, who recently joined Covington's EU competition group:
Zulli, 40, will work mainly in pharmaceuticals and life sciences sectors in his new firm. He says it was a hard decision to leave Norton Rose – where he was local partner – but ultimately he wanted to return to Brussels – “the heart of antitrust in Europe”.
“Not only ...
October 20, 2014, Covington E-Alert
October 20, 2014, The Washington Post
"Covington & Burling of the District appointed Ashley Bass, Robin Blaney, Krista Carver, Jeffrey Davidson, Nicole Duclos, Shankar Duraiswamy, Scott Freling, David Garr, Jason Goldberg, Andrew Lazerow, Michael Lechliter, Anne Lee, Scott Schrader, Nathan Shafroth and Ranganath Sudarshan partners."
October 17, 2014, The Lawyer
Partners Louise Nash and Simon Amies are mentioned in this article regarding their representation of Qualcomm:
"Covington & Burling advised US mobile phone chipmaker Qualcomm and Slaughter and May advised tech firm CSR on the US company’s £1.6bn takeover of the British company, which will increase Qualcomm’s presence in the UK."
October 16, 2014, Lawyer 2B
October 10, 2014
LONDON, 10 October, 2014 — Covington & Burling is advising Consort Medical plc on the acquisition of Aesica Holdco Limited and its operating subsidiaries from private equity fund Silverfleet Capital and its management shareholders for a total consideration of approximately £230 million. Covington is also advising Consort Medical plc on the £98.9 million Rights ...
WASHINGTON, DC, October 1, 2014 — Covington & Burling is pleased to announce that it has elected 15 lawyers to its partnership effective today. “Our new partners come from six firm offices and practice in a variety of areas that are of great importance to the firm’s clients,” said Timothy Hester, chair of Covington’s management committee. “These are all superb ...
October 7, 2014
LONDON, 7 October, 2014 — Covington & Burling advised Horizon Discovery Group plc, an AIM listed international life science company supplying research tools and services to organizations engaged in genomics research and the development of personalized medicines, on the acquisition of Sage Labs Inc. for a total of approximately $48 million (£29 million), ...
October 3, 2014, Covington E-Alert
October 1, 2014, Covington E-Alert
September 29, 2014, Luxury Legal Post
London, October 9, 2014 - Covington & Burling has been selected as the winner in the Technology, Media and Telecoms category of Legal 500 UK Awards 2014, with a focus on Data Protection. Covington’s European technology, media and telecoms lawyers draw on the firm’s deep roots in the software, Internet, telecommunications and media industries and act as strategic ...
September 2014, Money Laundering Bulletin
September 2014, World Data Protection Report
Peter Flanagan and David Lorello have co-authored this piece on US and EU sanctions targeting Iran:
"On 19 July 2014, the United States, the United Kingdom, Germany, France, Russia, and China (the “P5+1”) and Iran mutually consented to extend the Joint Plan of Action (JPOA), reached by the parties on 24 November 2013, for an additional four-month period, to 24 ...
August 25, 2014
WASHINGTON, DC, August 25, 2014 — Covington & Burling has been named to Latinvex’s “Legal 50,” a list of top international law firms doing work in Latin America. The firm ranked seventh among the top 15 firms doing international arbitration work in Latin America and 27th overall. Latinvex evaluated more than 100 international law firms and selected the top 50 ...
August 12, 2014, Money Laundering Bulletin
July 2014, Covington E-Alert
August 7, 2014, Covington E-Alert
August 7, 2014
LONDON, 7 August, 2014 — Covington advised Ergomed plc, an international clinical research business, on its flotation on the AIM market of the London Stock Exchange, an associated fundraising and its simultaneous acquisition of PrimeVigilance Limited, a leading provider of pharmacovigilance and medical information services. Ergomed ‘s market capitalisation on ...
August 5, 2014, Law360
August 5, 2014
LONDON, 5 August, 2014 — Covington & Burling advised Illumina on its partnership with Genomics England to provide infrastructure and expertise for a four-year project that aims to make the UK the world leader in genetic research into cancer and rare diseases, through funding research to decode 100,000 human genomes - a patient's personal DNA code. The deal is ...
July/August 2014, The Banking Law Journal
July 31, 2014, InsideEnergy&Environment Blog
July 30, 2014
LONDON, 30 July, 2014 — Covington & Burling advised AstraZeneca on its agreement to transfer to the company the rights to Almirall’s respiratory franchise for an initial consideration of $875 million on completion, and up to $1.22 billion in development, launch, and sales-related milestones. AstraZeneca has also agreed to make various sales-related payments. ...
July 30, 2014, Bloomberg
July 30, 2014, Legal Business
Lucinda Osborne, Gregor Frizzell, Christopher Walter and Miranda Cole are mentioned regarding their representation of AstraZeneca on its £1.2bn acquisition of Spanish healthcare group Almirall’s respiratory unit.
July 28, 2014, Covington E-Alert
July 16, 2014, Covington E-Alert
July 11, 2014, Law360
Jeremy Wilson and William Lowery have authored this article on the allegations that Naftogaz has failed to pay $4.5 billion for gas that Gazprom has already delivered to Naftogaz.
"On June 16, 2014, Gazprom announced that it had commenced arbitration proceedings against Naftogaz under the Stockholm Chamber of Commerce rules alleging that Naftogaz has failed to ...
July 10, 2014
LONDON, 2 June, 2014 — Oxford BioMedica plc, a Main Market listed gene based biopharmaceutical company, announced that it intends to raise gross proceeds of up to £25.7 million through a fundraising by means of a placing and subscriptions and an open offer. Covington & Burling advised the company on the transaction. The proceeds of the fundraising will be used ...
LONDON, 10 July, 2014 — Rightster Group plc, an AIM-listed cloud-based global video distribution and monetisation network, announced the acquisition of Viral Management Limited, the proposed acquisition of Base79 Limited and the placing of new shares by Cenkos to raise £42 million for the company. Covington & Burling advised Rightster on these transactions, ...
July 8, 2014, Covington E-Alert
July 7, 2014
LONDON, 7 July, 2014 — Euromoney Legal Media Group awarded Covington partners Lisa Peets and Carmen Martinez Lopez the ‘Best in Copyright’ and ‘Rising Star - Litigation’ awards at the annual European Women in Business Law Awards ceremony in London. The awards honour firms that set “the standard in terms of female-friendly work practices, and women leading the ...
June 2014, Covington E-Alert
July 1, 2014, Law360
June 26, 2014, Covington E-Alert
June 16, 2014, Lexis®PSL Arbitration
May 2014, Covington E-Alert
June 5, 2014
LONDON, 5 June, 2014 —Horizon Discovery Group plc, an AIM listed international life science company supplying research tools and services to organizations engaged in genomics research and the development of personalized medicines, announced its acquisition of the CombinatoRx service business and related assets from Nasdaq listed Zalicus Inc., a biopharmaceutical ...
June 3, 2014
WASHINGTON, DC, June 3, 2014 — The National Law Journal has named Covington & Burling to its 2014 “Intellectual Property Hot List,” which recognizes 20 firms that have “become leaders on the latest trends in intellectual property law.” This is the second time since 2012 that Covington has been named to the list. In naming Covington to the list, the NLJ cited the ...
May 29, 2014, Covington E-Alert
May 27, 2014
WASHINGTON, DC, May 27, 2014 —Covington & Burling was named the “Transfer Pricing Advisory Firm of the Year - Washington D.C.” by Corporate LiveWire, a global news resource for corporate finance professionals. The Corporate LiveWire Global Awards honor law firms, individuals and businesses who have demonstrated distinction in corporate finance, and consistently ...
May 21, 2014, Covington E-Alert
May 6, 2014, Covington E-Alert
April 2014, Covington E-Alert
May 2, 2014
LONDON, 1 May, 2014 — Euromoney Legal Media Group have shortlisted nine Covington lawyers for the annual ‘Europe Women in Business Law Awards’ 2014. Those shortlisted for “Best in” their respective practice areas are:
Competition and Antitrust - Miranda Cole
Copyright - Lisa Peets
Financial Regulation - Charlotte Hill
Life Sciences - Lucinda Osborne ...
May 1, 2014
LONDON, 1 May, 2014 — Covington & Burling advised Lombard Medical, Inc. on its $55 million U.S. initial public offering and the listing of the company’s ordinary shares on the NASDAQ Global Market. Covington also advised the company on its change of domicile from the U.K. to the Cayman Islands and the delisting of its shares from the AIM market of the London ...
April 17, 2014, Covington E-Alert
April 17, 2014
WASHINGTON, DC, April 17, 2014 — Covington & Burling is pleased to announce the promotion of four lawyers to of counsel and three lawyers to special counsel, effective April 1, 2014. The new of counsel are as follows: Lindsay Burke advises U.S., international, and multinational employers on employee management issues and international HR compliance. Her domestic ...
April 7, 2014
WASHINGTON, DC, April 7, 2014 — Covington & Burling partners Simon Amies, Scott Anthony and Andrew Jack spoke at the 2014 CleanEquity Monaco conference in the Principality of Monaco on March 27 and 28. The annual conference, sponsored in part by Covington and hosted by London-based Innovator Capital, aims to accelerate cleantech innovation and provide expert ...
April 7, 2014, The Lawyer
Covington's Paul Claydon, Natalie Walter, Guy Dingley, and Sarah Hoult are mentioned regarding their representation of Horizon Discovery on their IPO.
April 1, 2014, Covington E-Alert
March 2014, Covington E-Alert
March 31, 2014
LONDON, 31 March, 2014 — Horizon Discovery Group plc announced the admission of its shares to the AIM market of the London Stock Exchange. Covington & Burling advised Horizon on the transaction. The IPO raised approximately £40 million before expenses for Horizon and a further £28.6 million for selling shareholders, which puts a market capitalisation on the ...
March 28, 2014
LONDON, 28 March, 2014 — Covington & Burling advised Charles Stanley Securities acting as nominated adviser and WG Partners acting as financial adviser and broker to Venture Life Group plc, the international consumer healthcare company, on its admission to AIM. On admission to AIM, Venture Life will complete the acquisition of Biokosmes Srl, an Italian company ...
WASHINGTON, DC, March 26, 2014 — The U.S. Senate today confirmed Covington & Burling partner Christopher “Casey” Cooper to the U.S. District Court for the District of Columbia. Mr. Cooper was approved by a unanimous vote.“We are very proud that President Obama nominated Casey for a federal judgeship and that the Senate has now confirmed his nomination. We know ...
March 25, 2014
LONDON, 25 March, 2014 — Covington & Burling advised Vectura Group Plc, a product development company that focuses on the development of pharmaceutical therapies for the treatment of airways-related diseases, on its acquisition of German pharmaceutical company Activaero GmbH for a total consideration of €130 million (£108 million) and related fundraising to ...
March 5, 2014, Covington E-Alert
March 5, 2014, Covington E-Alert & Advisory
February 2014, Covington E-Alert
February/March 2014, World Trademark Review
February 18, 2014, Covington E-Alert
February 6, 2014
WASHINGTON, DC, February 6, 2014 — Law360 has named Covington & Burling’s insurance group as one of eight “Insurance Groups of the Year.” In its profile of the firm, Law360 recognized the firm’s strength in the insurance practice, including “scoring a marquee win” for MF Global Inc. and its work in “headline-grabbing insurance disputes” for clients such as BP ...
January 27, 2014, Law360
January 13, 2014
WASHINGTON, DC, January 13, 2014 — For the second consecutive year, Law360 has named Covington & Burling’s life sciences practice as one of the top five “Life Sciences Practice Groups of the Year.” In a profile of the firm, Law360 noted that Covington “delivered for drugmakers on three continents in 2013, spearheading a momentous investment by U.K.-based ...
LONDON, 13 January, 2014 — Covington & Burling advised Isarna Therapeutics GmbH on an agreement with Santaris Pharma A/S whereby Isarna gains access to Santaris' Locked Nucleic Acid (LNA) technology to further develop its next generation oligonucleotide product candidates. Under the terms of the agreement, Isarna obtains rights to utilize Santaris Pharma's ...
January 9, 2014
LONDON, 9 January, 2014 — Covington & Burling advised Innovacell Biotechnologie AG on a collaboration and exclusive licensing agreement with Norgine BV. Under the terms of the agreement Innovacell and Norgine will co-develop, and Norgine will commercialise, ICEF15 - an innovative personalised cell therapy to treat faecal incontinence. The agreement territory ...
January 7, 2014
WASHINGTON, DC, January 6, 2014 — For the second consecutive year, The National Law Journal has named Covington & Burling to its “Pro Bono Hot List.” This year’s list recognizes nine firms and one corporate law department for their strong commitment to public service. In the profile of Covington, the NLJ features the pro bono efforts of the firm’s New York ...
January 6, 2014
WASHINGTON, DC, January 6, 2014 — Law360 named Covington & Burling’s energy practice as one of the top five “Energy Practice Groups of the Year.” In giving this award, Law360 recognized the breadth of Covington’s practice capabilities (including litigation, transactions, regulatory and government policy) in both the traditional and emerging energy sectors and ...
January 2014, Scrip Regulatory Affairs
January 2014, Covington E-Alert
December 19, 2013
NEW YORK, December 19, 2013 — Covington & Burling advised AstraZeneca in its acquisition of Bristol-Myers Squibb's interests in the companies’ diabetes alliance for an initial consideration of $2.7 billion on completion and up to $1.4 billion in regulatory, launch and sales-related payments.
AstraZeneca has also agreed to pay various sales-related royalty ...
December 9, 2013
WASHINGTON, DC, December 9, 2013 — For the sixth consecutive year, the Human Rights Campaign Foundation has awarded Covington & Burling the top rating of 100 percent in the 2014 Corporate Equality Index. Covington’s 100 percent rating reflects its written non-discrimination policy, sexual orientation and gender identity training, and support for same-sex ...
LONDON, 4 December, 2013 — London associate Emilie Jones has been named ‘Associate Solicitor of the Year’ as part of Legal Week’s The British Legal Awards. Ms. Jones was recognised for her innovative work for Covington’s brands practice, which focuses on the strategic challenges that brands face, from creating new brands, to diversifying into new markets, and ...
December 2, 2013, Covington E-Alert
November 27, 2013, Covington E-Alert
November 12, 2013
LONDON, 12 November, 2013 — Rightster Group plc., a global provider of cloud-based services that optimise the distribution and monetisation of live and on-demand video, today announced the admission of its shares to the AIM market of the London Stock Exchange. Covington & Burling advised Rightster on the transaction.
Rightster has raised £20.4 million before ...
November 1, 2013, Compliance Monitor
November 2013, Covington E-Alert
November 2013, PLC Guide to Corporate Crime, Fraud and Investigations
October 24, 2013, Covington E-Alert
October 22, 2013, Covington E-Alert
October 18, 2013
LONDON, 18 October, 2013 — AstraZeneca announced that MedImmune, its global biologics research and development arm, has acquired Spirogen, a privately-held biotech company focused on antibody-drug conjugate technology for use in oncology. Covington & Burling advised AstraZeneca on the transaction working alongside AstraZeneca’s in-house legal team. MedImmune has ...
October 17, 2013, Covington E-Alert
October 4, 2013, Covington E-Alert
October 1, 2013
WASHINGTON, DC, October 1, 2013 — Covington & Burling is pleased to announce that it has elected nine lawyers to its partnership effective today. “We’re delighted to welcome these nine lawyers to our partnership,” said Timothy Hester, chair of Covington’s management committee. “They are all excellent lawyers who will bring great value and service to our clients ...
September 23, 2013, Covington E-Alert
September 9, 2013
LONDON, 9 September, 2013 — Covington & Burling is pleased to announce that Charlotte Hill has joined its London office as partner, strengthening the firm’s ability to advise clients on EU and UK financial regulatory matters.
Ms. Hill advises financial institutions on regulatory and commercial matters and has extensive experience assisting fund management ...
September 6, 2013, Covington E-Alert
September 3, 2013
SAN FRANCISCO, September 3, 2013 — Covington & Burling is advising Microsoft Corp. in its purchase of substantially all of Nokia’s devices & services business. Under the transaction, Microsoft will also license Nokia’s patents, and license and use Nokia’s mapping services. The total transaction price is EUR 5.44 billion in cash — or more than $7 billion.
September 2013, Listed Private Equity Brief
August 9, 2013, Covington Advisory
August 2013, Journal of Medical Device Regulation
July 22, 2013
LONDON, 22 July, 2013 — Covington & Burling acted for AIM listed stem cell therapy company, ReNeuron Group plc, on its £33 million fund raising.
ReNeuron today announced that £25.35 million (before expenses) will be raised through an oversubscribed placing of new shares to fund the company’s therapeutic programmes through Phase II trials, together with a £7.8 ...
July 12, 2013
WASHINGTON, DC, July 12, 2013 — Covington & Burling has been recognized as an honoree with two American Lawyer Global Legal Awards: Global Dispute of the Year, Investment Arbitration and Global M&A Deal of the Year, Canada. Covington’s International Arbitration Group, comprised of more than 50 lawyers, handles cases under the rules of every major arbitration ...
July 11, 2013
WASHINGTON, DC, July 11, 2013 — For the third consecutive year, Covington & Burling has received a Gold Standard Certification from the Women In Law Empowerment Forum (WILEF), a leading organization dedicated to assisting women in law to assume leadership roles in private law firms, corporate legal departments, and the legal community at large. The certification ...
WASHINGTON, DC, July 11, 2013 — Thomson Reuters has ranked Covington & Burling among the Top 20 legal advisers worldwide in completed M&A transactions in emerging markets during the first half of 2013. Covington ranked among the top 10 for deals involving China and the Asia Pacific region, and among the top 15 for deals involving Latin America. “We have made a ...
WASHINGTON, DC, July 10, 2013 — Covington & Burling advised Governance for Owners (GO) in the formation of a new, global partnership with Engaged Capital (EC) in the activist investing arena. In addition to sharing marketing efforts, EC and GO plan to collaborate to launch a global constructive activist strategy. Based in Newport Beach, Calif., EC invests in ...
LONDON, 2 July, 2013 — Covington & Burling LLP is pleased to announce that Ben Holland and Jeremy Wilson are joining the firm’s London office as partners. Both will practice in Covington’s international arbitration and commercial litigation practice groups, focusing on energy-related disputes. They are joining a well-established team that has been at the ...
July 2013, European Chamber of Commerce in Korea (ECCK)
July 2013, ACORE Transportation Industry Review
June 28, 2013
WASHINGTON, DC, June 28, 2013 — Covington & Burling’s international arbitration practice has been shortlisted for a Chambers Latin America Award for Excellence. The awards recognize notable achievements over the past year, including outstanding work, impressive strategic growth, and excellence in client service. The Chambers Latin America Awards for Excellence ...
June 26, 2013
LONDON, 26 June, 2013 — The UK Information Commissioner's Office has authorised GlaxoSmithKline’s 'Binding Corporate Rules' (BCRs) – a set of internal policies and procedures used to protect personal data across GSK’s operations globally. The privacy and data security team at Covington & Burling was instrumental in the development, implementation and ...
June 21, 2013
LONDON, 21 June, 2013 — Euromoney LMG awarded Covington partners Lisa Peets and Hilary Prescott the "Best in Copyright" and "Best in Investment Funds" awards at its Europe Women in Business Law Awards 2013 ceremony in London. The awards honour firms that set “the standard in terms of female-friendly work practices, and women leading the field in the legal sector ...
June 20, 2013
LONDON, 20 June, 2013 — Covington & Burling acted for Canaccord Genuity Limited (nominated adviser and joint broker) and WG Partners, a trading name of Charles Stanley & Co. Ltd (joint broker), to AIM-quoted Lombard Medical Technologies plc on its placing and subscription of ordinary shares to raise approximately £22 million before expenses.
Lombard is a ...
June 2013, International Arbitration Law Review Volume 16 Issue 3
May 23, 2013, Law360
May 23, 2013, Inside EU LifeSciences Blog
May 20, 2013, The Global Legal Post
May 15, 2013, Webinar
May 15, 2013, The Global Legal Post
May 3, 2013, Covington E-Alert
May 2, 2013
LONDON, 2 May, 2013 — Silence Therapeutics Plc, a leader in the discovery, development and delivery of novel RNA interference therapeutics for the treatment of serious diseases, has successfully raised £18.7 million of new funds. Covington & Burling advised Silence Therapeutics on the transaction. The Company expects to use the net proceeds of the placing of ...
May 1, 2013, Covington Advisory
April 18, 2013
LONDON, 18 April, 2013 — Covington & Burling LLP acted for WH Ireland, nominated adviser and broker to Thalassa Holdings Ltd, on a £5.4 million placing of ordinary shares for Thalassa Holdings. Thalassa Holdings Ltd, incorporated and registered in the British Virgin Islands and quoted on AIM, is a holding company with a focus on marine seismic operations. The ...
April 2013, The Life Sciences Law Review
April 2013, World Data Protection Report
March 28, 2013
WASHINGTON, DC, March 28, 2013 — Lanny A. Breuer, most recently the Assistant Attorney General for the Criminal Division at the U.S. Department of Justice, is returning to Covington & Burling as Vice Chair of the firm.
Mr. Breuer’s practice will encompass a wide range of civil and criminal litigation matters, as well as governmental and internal investigations. ...
March 25, 2013
LONDON, 25 March, 2013 — AstraZeneca and Moderna Therapeutics announced an agreement to develop and commercialise pioneering messenger RNA therapeutics™ for the treatment of serious cardiovascular, metabolic and renal diseases as well as cancer. Covington & Burling advised AstraZeneca on the deal, working alongside AstraZeneca’s in-house legal team. Under the ...
March 14, 2013
WASHINGTON, DC, March 14, 2013 — Congressman Howard Berman, a widely respected leader in the U.S. Congress, is joining Covington & Burling’s global public policy and government affairs practice.
The addition of Rep. Berman, the former chairman of the House Foreign Affairs Committee, comes a week after Sen. Jon Kyl joined Covington’s public policy and government ...
March 7, 2013, Webinar
March 6, 2013
WASHINGTON, DC, March 6, 2013 — Senator Jon Kyl, who recently left Congress as the second-highest ranking Republican in the U.S. Senate, is joining Covington & Burling’s global public policy and government affairs practice.
“Senator Kyl’s deep knowledge and extraordinary legislative skills from his years as a senior leader in Congress make him ideally suited to ...
February 26, 2013
LONDON, 26 February, 2013 — Covington & Burling advised The Hut Group Limited, one of Europe’s fastest growing online retailers and brand owners, on an equity fundraising in line with its category expansion strategy.
The London-based Covington team was led by corporate partners Natalie Walter and Kristian Wiggert, with assistance from corporate associates Karen ...
February 25, 2013
London, February 25, 2013 — Global Arbitration Review has named Covington & Burling to its list of the world’s top 30 international arbitration practices.
In announcing the GAR 30 list, the publication notes Covington’s major arbitral victories last year, including the award for Spanish investors in Yukos Oil Company in Quasar de Valores SICAV S.A., et al. v. ...
February 20, 2013, Covington E-Alert
February 19, 2013, Covington E-Alert
February 15, 2013, Covington Advisory
February 14, 2013, Covington E-Alert
February 4, 2013, Webinar
January 30, 2013, Covington E-Alert
January 22, 2013, Covington Advisory
January 22, 2013
WASHINGTON, DC, January 22, 2013 — For the second straight year, Law360 named Covington & Burling’s global privacy and data security practice as one of the top five “Privacy & Consumer Protection Practice Groups of the Year.”
In a profile highlighting the firm’s privacy-related work, Law360 noted the group’s recent litigation win for LinkedIn Corp. In that case, ...
WASHINGTON, DC, January 22, 2013 — Law360 named Covington’s life sciences practice as of one of the top five “Life Sciences Practice Groups of the Year.”
In a profile highlighting Covington’s life sciences practice, Law360 noted that the group has “grown to develop an increasingly global reach that has made it a go-to for complex transactions, high stakes ...
January 2013, The Privacy Advisor
2013, Competition Law Insight
December 28, 2012
BEIJING, December 28, 2012 — Chambers has named Covington & Burling as a finalist for the 2013 Chambers China Awards for Excellence in the International Trade category.
The awards recognize preeminence in key practice areas and significant achievements over the past 12 months, including outstanding work, impressive strategic growth and excellence in client ...
December 13, 2012, Covington Advisory
December 11, 2012, Covington E-Alert
December 11, 2012
LONDON, 11 December, 2012 — Covington & Burling acted as legal advisers to Meda in its acquisition of MidNite, an OTC sleep-aid product. Meda is a leading international specialty pharmaceutical company.
The Covington team was led by partner Peter Laveran with assistance from Karen Brooks. The team also included Philip Young and trainee Philippe Bradley ...
November 21, 2012, Covington E-Alert
November 1, 2012
WASHINGTON, DC, November 1, 2012 — Covington & Burling opens its Seoul office today after securing final approval from the Korean Ministry of Justice and the Korean Bar Association.
The new office will be located in the Meritz Tower, at 825-2, Yeoksamdong in the heart of Seoul’s Gangnam business district.
“We are honored to be among the first U.S. law firms to ...
October 24, 2012, Covington Advisory
October 19, 2012, Covington E-Alert
October 17, 2012
LONDON, 17 October, 2012 — Covington & Burling’s London office has been awarded a Lex Medal for “Confidence in being kept on” in the 2012/13 Lex 100 trainee survey. The Lex 100 is an online comparative guide to leading law firms aimed at those considering a career in law, based on the views of the trainees of the firms.
Covington also scored especially highly ...
October 16, 2012, Covington E-Alert
LONDON, October 4, 2012 — Covington & Burling advised the Giorgio Armani Group on the acquisition of its retail and wholesale business from long-term retail partner Club 21. Under the terms of the deal, announced Tuesday, Armani has taken direct control of sales for its leading brands, which include Giorgio Armani, Emporio Armani, Armani Collezioni and Armani ...
October 2, 2012, American Employment Law Council
October 1, 2012, Covington E-Alert
October 2012, LPEQ Listed Private Equity Briefing
September 27, 2012, Covington webinar
September 26, 2012, Covington E-Alert
September 24, 2012
LONDON, 24 September, 2012 — Covington & Burling LLP acted as US counsel to Eland Oil & Gas PLC, a West Africa-focused energy firm, in connection with its initial offering on the AIM market of the London Stock Exchange PLC.
The offering, which closed on September 3, raised £118 million ($189 million), making it the largest AIM flotation in more than three ...
September 17, 2012, Covington Advisory
September 11, 2012, Covington E-Alert
September 10, 2012, Briefing paper for the BioIndustry Association
September 6, 2012
LONDON, 06 September, 2012 — Covington & Burling LLP acted as legal advisers to Meda in an agreement with Jazz Pharmaceuticals to acquire a portfolio of six pharmaceutical products for women for $95 million in cash.
The largest and most important prod